Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2001 2
2002 3
2003 3
2004 5
2005 6
2006 3
2007 4
2009 2
2010 3
2011 3
2012 4
2013 3
2014 5
2015 9
2016 3
2017 1
2018 8
2019 6
2020 8
2021 6
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial.
Peters S, Danson S, Hasan B, Dafni U, Reinmuth N, Majem M, Tournoy KG, Mark MT, Pless M, Cobo M, Rodriguez-Abreu D, Falchero L, Moran T, Ortega Granados AL, Monnet I, Mohorcic K, Sureda BM, Betticher D, Demedts I, Macias JA, Cuffe S, Luciani A, Sanchez JG, Curioni-Fontecedro A, Gautschi O, Price G, Coate L, von Moos R, Zielinski C, Provencio M, Menis J, Ruepp B, Pochesci A, Roschitzki-Voser H, Besse B, Rabaglio M, O'Brien MER, Stahel RA. Peters S, et al. Among authors: danson s. J Thorac Oncol. 2020 Oct;15(10):1647-1656. doi: 10.1016/j.jtho.2020.06.011. Epub 2020 Jun 18. J Thorac Oncol. 2020. PMID: 32565388 Free article. Clinical Trial.
Are we over-treating with checkpoint inhibitors?
Danson S, Hook J, Marshall H, Smith A, Bell S, Rodwell S, Corrie P. Danson S, et al. Br J Cancer. 2019 Oct;121(8):629-630. doi: 10.1038/s41416-019-0570-y. Epub 2019 Sep 17. Br J Cancer. 2019. PMID: 31527686 Free PMC article.
The care of older cancer patients in the United Kingdom.
Gomes F, Lewis A, Morris R, Parks R, Kalsi T, Babic-Illamn G, Baxter M, Colquhoun K, Rodgers L, Smith E, Greystoke A, Bayman N, Cree A, Ng C, de Liguori Carino N, Basile S, Moore J, Merchant Z, Swinson D, Parbhoo A, Jones R, Davies E, Danson SJ, Young R, Morgan J, Wyld L, Corrie PG, Doherty GJ, Crawford K, Wright J, Reed M, Ugolini F, Lind M, Cheung KL, Harari D, Simcock R. Gomes F, et al. Among authors: danson sj. Ecancermedicalscience. 2020 Sep 15;14:1101. doi: 10.3332/ecancer.2020.1101. eCollection 2020. Ecancermedicalscience. 2020. PMID: 33082851 Free PMC article. Review.
Tamoxifen ("Nolvadex"): a review.
Clemons M, Danson S, Howell A. Clemons M, et al. Among authors: danson s. Cancer Treat Rev. 2002 Aug;28(4):165-80. doi: 10.1016/s0305-7372(02)00036-1. Cancer Treat Rev. 2002. PMID: 12363457 Review.
Melanoma vaccines--they should work.
Danson S, Lorigan P. Danson S, et al. Ann Oncol. 2006 Apr;17(4):539-41. doi: 10.1093/annonc/mdl055. Ann Oncol. 2006. PMID: 16556849 Free article. No abstract available.
Perspectives on novel therapies for bronchial carcinoma.
Blackhall F, Papakotoulas PI, Danson S, Thatcher N. Blackhall F, et al. Among authors: danson s. Expert Opin Pharmacother. 2005 Jun;6(7):1157-67. doi: 10.1517/14656566.6.7.1157. Expert Opin Pharmacother. 2005. PMID: 15957969 Review.
IAPs as a target for anticancer therapy.
Danson S, Dean E, Dive C, Ranson M. Danson S, et al. Curr Cancer Drug Targets. 2007 Dec;7(8):785-94. doi: 10.2174/156800907783220471. Curr Cancer Drug Targets. 2007. PMID: 18220537 Review.
Temozolomide: a novel oral alkylating agent.
Danson SJ, Middleton MR. Danson SJ, et al. Expert Rev Anticancer Ther. 2001 Jun;1(1):13-9. doi: 10.1586/14737140.1.1.13. Expert Rev Anticancer Ther. 2001. PMID: 12113120 Review.
81 results